Holly Mikulski

Experience

1. Account Executive

   MiMedx

   Jan 2022 — Present

   MIMEDX is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue with patented-protected processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than 2.5 million allografts through both direct and consignment shipments. As a company, we are driven to bring hope to people with hard-to-heal wounds. Our ability to advance science will further differentiate the value of our business and set the foundation for our platform portfolio to address other areas of unmet need.